Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-63,866,440
Closed -$368M 1856
2017
Q1
$368M Buy
63,866,440
+1,148,134
+2% +$6.3M 0.45% 56
2016
Q4
$308M Buy
62,718,306
+13,207,554
+27% +$71.3M 0.39% 65
2016
Q3
$302M Buy
49,510,752
+6,973,195
+16% +$41.7M 0.38% 68
2016
Q2
$251M Buy
+42,537,557
New +$228M 0.33% 83
2016
Q1
Sell
-13,067
Closed -$58K 1682
2015
Q4
$58K Sell
13,067
-6,685,618
-100% -$32.7M ﹤0.01% 1734
2015
Q3
$32.8M Sell
6,698,685
-27,265,523
-80% -$148M 0.04% 422
2015
Q2
$207M Sell
33,964,208
-43,431,507
-56% -$268M 0.24% 114
2015
Q1
$446M Buy
77,395,715
+7,757,920
+11% +$48.2M 0.5% 41
2014
Q4
$433M Buy
69,637,795
+23,382,040
+51% +$148M 0.48% 46
2014
Q3
$303M Buy
46,255,755
+15,546,920
+51% +$109M 0.33% 75
2014
Q2
$216M Sell
30,708,835
-6,316,825
-17% -$46.5M 0.24% 116
2014
Q1
$274M Sell
37,025,660
-166,450
-0.4% -$1.17M 0.32% 81
2013
Q4
$273M Buy
+37,192,110
New +$272M 0.33% 72

Other funds holding ABEV

OppenheimerFunds's ABEV Position: Q2 2017 in Review

OppenheimerFunds sold out of Ambev (ABEV) in Q2 2017, closing a stake of 63,866,440 shares — an estimated $368M sold.

OppenheimerFunds first reported a position in ABEV in Q4 2013 and held it in 13 quarters. The position peaked at $446M in Q1 2015. 301 funds tracked by Wall St. Rank hold ABEV as of Q2 2017.

  • OppenheimerFunds reported no remaining Ambev position as of Q2 2017 after selling out during the quarter.
  • OppenheimerFunds sold 63,866,440 Ambev shares in Q2 2017, an estimated $368M.
  • OppenheimerFunds first reported a position in Ambev in Q4 2013 and held it in 13 quarters.
  • OppenheimerFunds's Ambev position peaked at $446M in Q1 2015.
  • 301 funds tracked by Wall St. Rank held Ambev as of Q2 2017.

Based on OppenheimerFunds's 13F filing for Q2 2017, filed 14 Aug 2017.